1. Home
  2. XENE vs IPAR Comparison

XENE vs IPAR Comparison

Compare XENE & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • IPAR
  • Stock Information
  • Founded
  • XENE 1996
  • IPAR 1982
  • Country
  • XENE Canada
  • IPAR United States
  • Employees
  • XENE N/A
  • IPAR N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • IPAR Package Goods/Cosmetics
  • Sector
  • XENE Health Care
  • IPAR Consumer Discretionary
  • Exchange
  • XENE Nasdaq
  • IPAR Nasdaq
  • Market Cap
  • XENE 2.9B
  • IPAR 3.1B
  • IPO Year
  • XENE 2014
  • IPAR 1988
  • Fundamental
  • Price
  • XENE $42.30
  • IPAR $91.70
  • Analyst Decision
  • XENE Strong Buy
  • IPAR Strong Buy
  • Analyst Count
  • XENE 10
  • IPAR 5
  • Target Price
  • XENE $53.00
  • IPAR $154.60
  • AVG Volume (30 Days)
  • XENE 742.2K
  • IPAR 238.5K
  • Earning Date
  • XENE 11-03-2025
  • IPAR 11-05-2025
  • Dividend Yield
  • XENE N/A
  • IPAR 3.49%
  • EPS Growth
  • XENE N/A
  • IPAR 14.29
  • EPS
  • XENE N/A
  • IPAR 5.02
  • Revenue
  • XENE $7,500,000.00
  • IPAR $1,458,888,000.00
  • Revenue This Year
  • XENE N/A
  • IPAR $4.18
  • Revenue Next Year
  • XENE $207.88
  • IPAR $5.35
  • P/E Ratio
  • XENE N/A
  • IPAR $18.27
  • Revenue Growth
  • XENE N/A
  • IPAR 7.04
  • 52 Week Low
  • XENE $26.74
  • IPAR $91.06
  • 52 Week High
  • XENE $46.00
  • IPAR $148.15
  • Technical
  • Relative Strength Index (RSI)
  • XENE 59.76
  • IPAR 30.47
  • Support Level
  • XENE $40.79
  • IPAR $91.06
  • Resistance Level
  • XENE $43.33
  • IPAR $100.73
  • Average True Range (ATR)
  • XENE 1.59
  • IPAR 2.83
  • MACD
  • XENE -0.05
  • IPAR 0.34
  • Stochastic Oscillator
  • XENE 60.49
  • IPAR 6.62

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

Share on Social Networks: